Buck Institute | GenomeWeb

Buck Institute

The patent is based on the work of Aelan's founder and covers an epigenetic  biomarker associated with DNA damage, cellular senescence, and aging.

A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

A recent protein interaction study revealed that invertebrates have more in common with humans when it comes to the aging process than had been previously known, and that "the broad patterns underlying genetic control of life span in invertebrates is highly relevant to human aging and longevity."

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.